Glia-conditioned medium induces De Novo synthesis of tyrosine hydroxylase and increases dopamine cell survival by differential signaling pathways

Journal of Neuroscience Research

Volumn 73, Issue 6, 2003, Pages 818-830

  De Bernardo, S ^a   Canals, S ^a   Casarejos, M J ^a   Rodriguez Martin, E ^a   Mena, M A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Astrocytes; DA neurons; MAP ERK kinase; PI 3K; PKA; PKC; TrK receptors

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; DOPAMINE; GENISTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KT 5720; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAUROSPORINE; TYROSINE 3 MONOOXYGENASE; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CELL; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; GLIA CONDITIONED MEDIUM; MESENCEPHALON; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TISSUE CULTURE;

ANIMALS; BLOTTING, WESTERN; CELL COUNT; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; ENZYME INHIBITORS; GAMMA-AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRITIUM; TYROSINE 3-MONOOXYGENASE;

EID: 0041837545     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10704     Document Type: Article

References (79)

1. Abe K, Saito H. 2000. The p44/42 mitogen-activated protein kinase cascade is involved in the induction and maintenance of astrocyte stellation mediated by protein kinase C. Neurosci Res 36:251-257.
2. Ahn NG, Weiel JE, Chan CP, Krebs EG. 1990. Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J Biol Chem 265:11487-11494.
3. Arenas E. 2002. Stem cells in the treatment of Parkinson's disease. Brain Res Bull 57:795-808.
4. Bazán E, López-Toledano MA, Redondo C, Paino CL, Herranz AS, Mena MA. 1999. Basic fibroblast growth factor and protein kinase A activators cooperate to induce the expression of tyrosine hydroxylase in striatal neural stem cells. Soc Neurosci Abstr 25:1530.
5. Beart PM, McDonald D. 1980. Neurochemical studies of the mesolimbic dopaminergic pathway: somatodendritic mechanisms and GABAergic neurons in rat ventral tegmentum. J Neurochem 34:1622-1629.
6. Bradford MM. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 72:248-254.
7. Canals S, Casarejos MJ, Rodríguez-Martín E, de Bernardo S, Mena MA. 2001. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures. J Neurochem 76:56-68.
8. Carpenter CL, Cantley LC. 1996. Phosphoinositide kinases. Curr Opin Cell Biol 8:153-158.
9. Chao MV, Bothwell M. 2002. Neurotrophins: to cleave or not to cleave. Neuron 33:9-12.
10. Chao M, Casaccia-Bonnefil P, Carter B, Chittka A, Kong H, Yoon SO. 1998. Neurotrophin receptors: mediators of life and death. Brain Res Rev 26:295-301.
11. Creedon DJ, Tansey MG, Baloh RH, Osborne PA, Lampe PA, Fahr TJ, Heuckeroth RO, Milbrandt J, Johnson EM Jr. 1997. Neuturin shares receptors and signal transduction pathway with glial cell line-derived neurotrophic factor in sympathet neurons. Proc Natl Acad Sci USA 94:7018-7023.
12. Damier P, Hirsch EC, Javoy-Agid F, Zhang P, Agid Y. 1993. Protective role of glutathione peroxidase against neuronal death in Parkinson's disease. Neuroscience 52:1-6.
13. Decker T, Lohmann-Matthes ML. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61-69.
14. Deckwerth TL. 1998. Molecular mechanisms of neuroprotection from neuronal death by trophic factor deprivation. In: Mattson MP, editors. Neuroprotective signal transduction. Totowa, NJ: Humana Press. p 61-82.
15. D'Mello SR, Borodezt K, Soltoff SP. 1997. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of P13-kinase in IGF-1 signaling. J Neurosci 17:1548-1560.
16. D'Onofrio M, Cuomo L, Battaglia G, Ngomba RT, Storto M, Kings AE, Orzi F, De Blasi A, Di Iorio P, Nicoletti F, Bruno V. 2001. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem 78:435-445.
17. Du X, Iacovitti L. 1997a. Protein kinase C activators work in synergy with specific growth factors to initiate cytosine hydroxylase gene expression in striatal neurons in culture. J Neurochem 68:564-569.
18. Du X, Iacovitti L. 1997b. Multiple signaling pathways direct the initiation of tyrosine hydroxylase gene expression in cultured brain neurons. Brain Res Mol Brain Res 50:1-8.
19. Du K, Montminy M. 1998. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273:32377-32379.
20. Dudek H, Datta SR, Franke TF, Birbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661-664.
21. Engele J, Schubert D, Bohn MC. 1991. Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia. J Neurosci Res 30:359-371.
22. Engele J, Rieck H, Choi-Lundberg D, Bohn MC. 1996. Evidence for a novel neurotrophic factor for dopaminergic neurons secreted from mesencephalic glial cell lines. J Neurosci Res 43:576-586.
23. Fernandez E, Graviso GL. 1999. Protein synthesis blockade differentially affects the degradation of constitutive and nicotinic receptor-induced tyrosine hydroxylase protein level in isolated bovine chromaffin cells. J Neurochem 73:169-178.
24. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. 1997. CREB: a major mediator of neuronal neurotrophin responses. Neuron 19:1031-1047.
25. Fukunaga K, Miyamoto E. 1998. Role of MAP kinase in neurons. Mol Neurobiol 16:79-95.
26. Fung BP, Yoon DM, Chikaraishi D. 1992. Sequences that direct rat tyrosine hydroxylase gene expression. J Neurochem 58:2044-2052.
27. Guo Z, Du X, Iacovitti L. 1998. Regulation of tyrosine hydroxylase gene expression during transdifferentiation of striatal neurons: changes in transcription factors binding the AP-1 site. J Neurosci 18:8163-8174.
28. Hilwig I. Gropp A. 1975. pH dependent fluorescence of DNA and RNA in cytologic staining with "33342 Hoechst." Exp Cell Res 91:457-460.
29. Hirsch EC, Hunot S. 2000. Nitric oxide, glial cells and neuronal degeneration in parkinsonism. Trends Pharmacol Sci 21:163-165.
30. Hirsch EC, Hunot S, Damier P, Brugg B, Faucheux BA, Michel PP, Ruberg M, Muriel MP, Mouatt-Prigent A, Agid Y. 1999. Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease. In: Stern GM, editor. Advances in neurology. Philadelphia: Lippincott Williams and Wilkins. p 9-18.
31. Hoffer BJ, Hoffman A, Bowekamp K, Huetd P, Hudson J, Martin D, Lin LF, Gerhardt GA. 1994. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182:107-111.
32. Johansson S, Stromberg I. 2002. Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon. J Comp Neurol 443:237-249.
33. Kim KS, Lee MK, Carroll J, Joh TH. 1993a. Both the basal and inducible transcription of the tyrosine hydroxilase gene are dependent upon a cAMP response element. J Biol Chem 268:15689-15695.
34. Kim KS, Park DH, Wessel TC, Song B, Wagner JA, Joh TH. 1993b. A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression. Proc Natl Acad Sci USA 90:3471-3475.
35. Kim KS, Tinti C, Song B, Cubells JF, Joh TJ. 1994. Cyclic AMP-dependent protein kinase regulates basal and cyclic AMP-stimulated but not phorbolester-stimulated transcription of the tyrosine hydroxylase gene. J Neurochem 63:834-842.
36. Kinor N, Geffen R, Golomb E, Zinman T, Yadid G. 2001. Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 33:143-150.
37. Kumer SC, Vrana KE. 1996. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443-462.
38. Levison SW, McCarthy KD. 1991. Astroglia in culture. In: Banker G, Goslin K, editors. Culturing nerve cells. Cambridge, MA: MIT Press. p 309-336.
39. Lewis EJ, Harrington CA, Chikaraishi D. 1987. Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoids and cAMP. Proc Natl Acad Sci USA 84:3550-3554.
40. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403-1409.
41. Lin LFH, Doherty DH, Lile JD, Bektosh S, Collins F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
42. Macinnis BL, Campenot RB. 2002. Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science 295:1536-1539.
43. Makar TK, Nedergaard M, Preuss A, Gelbard AS, Perumal AS, Cooper AJL. 1994. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J Neurochem 62:45-53.
44. Marshall CJ. 1990. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
45. Mena MA, Pardo B, Paíno CL, de Yébenes JG. 1993. Levodopa toxicity in foetal rat midbrain neurons in culture: modulation by ascorbic acid. Neuroreport 4:438-440.
46. Mena MA, Casarejos MJ, Carazo A, Paíno CL, García de Yébenes J. 1997. Glia protects midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms. J Neural Transm 104:317-328.
47. Mena MA, Casarejos MJ, Alcázar A, Herranz A, Paíno CL, García de Yébenes J. 1998. The critical factor for L-DOPA toxicity on dopamine neurons is glia. In: Castellano B, González B, Nieto-Sampedro M, editors. Understanding glial cells. Boston: Kluwer Academic Publishers. p 213-229.
48. Mena MA, Casarejos MJ, Garcia de Yébenes J. 1999. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity. J Neural Transm 106:1105-1123.
49. Mena MA, de Bernardo S, Casarejos MJ, Canals S, Rodriguez-Martin E. 2002. The role of astroglia on the survival of dopamine neurons. Mol Neurobiol 25:245-263.
50. Michel PP, Hefti F. 1990. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26:428-435.
51. Miller FD, Kaplan DR. 2002. TPK makes the retrograde. Science 295:1471-1473.
52. Moon LD, Asher RA, Rhodes KE, Fawcett JW. 2002. Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neuroscience 109:101-117.
53. Muller HW, Junghans U, Kappler J. 1995. Astroglial neurotrophic and neurite-promoting factors. Pharmacol Ther 65:1-18.
54. Panchision DM, Martin-DeLeon PA, Takeshima T, Johnston JM, Shimoda KT, Tsoulfas P, McKay KD, Commissiong JW. 1998. An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor. J Mol Neurosci 11:209-221.
55. Pardo B, Paino CL, Casarejos MJ, Mena MA. 1997. Neuronal-enriched cultures from embryonic rat ventral mesencephalon for pharmacological studies of dopamine neurons. Brain Res Protoc 1:127-132.
56. Piech-Dumas KM, Best JA, Chen Y, Nagamoto-Combs K, Osterhout C, Tank W. 2001. The cAMP responsive element and CKEB partially mediate the response of the tyrosine hydroxylase gene to phorbol ester. J Neurochem 76:1376-1385.
57. Pong K, Xu RY, Baron WF, Louis J-C, Beck KD. 1998. Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons. J Neurochem 71:1912-1919.
58. Rankin S, Hoosmand-Rad R, Claesson-Welsh L, Rozengurt E. 1996. Requirement for phosphatidylinositol 3′-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p125 focal adhesion kinase and paxillin. J Biol Chem 271:7829-7834.
59. Ray LB, Sturgill TW. 1988. Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc Natl Acad Sci USA 85:3753-3757.
60. Reuss B, Unsicker K. 2000. Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells. Mol Cell Neurosci 16:781-792.
61. Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH. 1989. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520.
62. Rodríguez-Martín E, Canals S, Casarejos MJ, de Bernardo S, Handler A, Mena MA. 2001. L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxyase expression in human catecholamine-rich neuroblastoma NB69 cells. J Neurochem 78:535-545.
63. Salinas M, Martín D, Alvarez A, Cuadrado A. 2001. AKT1/PKB protects PC12 cells against the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium and reduces the levels of oxygen-free radicals. Mol Cell Neurosci 17:67-77.
64. Sánchez S, Sayas L, Lim F, Diaz-Nido J, Avila J, Wandosell F. 2001. The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3. J Neurochem 78:468-481.
65. Satoh T, Nakatsuka D. Watanabe Y, Nagata I, Kikuchi H, Namura S. 2000. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett 288:163-166.
66. +-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells. J Neurochem 78:600-610.
67. Skaper SD, Floreani M, Negro A, Facci L, Giusti P. 1998. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein-kinase pathway. J Neurochem 70:1859-1868.
68. Song H, Stevens C, Gage F. 2002. Astroglia induce neurogenesis from adult neural stem cells. Nature 417:39-44.
69. Spear N, Estévez AG, Barbeito L, Beckman JS, Johnson GVW. 1997. Nerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase. J Neurochem 69:53-59.
70. Springer JE, Kitzman PH. 1998. Neuroprotective strategies involving the neurotrophins and their signaling pathways, In: Mattson MP. editor. Neuroprotective signal transduction. Totowa, NJ: Humana Press. p 1-21.
71. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW, DeFranco DB. 2000. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275:12200-12206.
72. Takeshima T, Johnston JM, Commissiong JW. 1994. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci 14:4769-4779.
73. Vila M, Jackson-Lewis V, Guégan C, Wu DC, Teismann P, Choi D-K, Tieu K, Przedborski S. 2001. The role of glial cells in Parkinson's disease. Curr Opin Neurol 14:483-489.
74. Wagner J, Akerud P, Castro DS, Holm PC, Canals JM, Snyder EY, Perlmann T, Arenas E. 1999. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat Biotechnol 17:653-659.
75. Walton M, Woodgate A-M, Muravlev A, Xu R, During M, Dragunow M. 1999. CREB phosphorylation promotes nerve cell survival. J Neurochem 73:1836-1842.
76. Wu DCh, Jackson-Lewis V, Vila M, Tieu K, Teissmann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
77. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
78. Yamazaki A, Chiba K, Mohri T, Hatanaka H. 2001. Activation of the mitogen-activated protein kinase cascade through nitric oxide synthesis as a mechanism of neuritogenic effect of genipin in PC12h cells. J Neurochem 79:45-54.
79. Zhou H, Li X, Meinkoth J, Pittman R. 2001. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 151:483-494.